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Abstract Glutamate is one of the major excitatory neuro-
transmitters of the CNS and is essential for numerous key
neuronal functions. However, excess glutamate causes mas-
sive neuronal death and brain damage owing to excitotoxicity
via the glutamate receptors. Metabotropic glutamate receptor
5 (mGluR5) is one of the glutamate receptors and represents a
promising target for studying neuroprotective agents of poten-
tial application in neurodegenerative diseases. Pu-erh tea, a
fermented tea, mainly produced in Yunnan province, China,
has beneficial effects, including the accommodation of the
CNS. In this study, pu-erh tea markedly decreased the tran-
scription and translation of mGluR5 compared to those by
black and green teas. Pu-erh tea also inhibited the expression
of Homer, one of the synaptic scaffolding proteins binding to
mGluR5. Pu-erh tea protected neural cells from necrosis via
blocked Ca2+ influx and inhibited protein kinase C (PKC)
activation induced by excess glutamate. Pu-erh tea relieved
rat epilepsy induced by LiCl-pilocarpine in behavioural and
physiological assays. Pu-erh tea also decreased the expression
of mGluR5 in the hippocampus. These results show that the
inhibition of mGluR5 plays a role in protecting neural cells
from glutamate. The results also indicate that pu-erh tea con-
tains biological compounds binding transcription factors and
inhibiting the expression ofmGluR5 and identify pu-erh tea as
a novel natural neuroprotective agent.
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Introduction
Glutamate, the primary excitatory neurotransmitter in the
brain, plays various physiological roles in cognition, memory
and perception via the activation of multiple receptors [1]. An
increase in the extracellular levels of glutamate leads to
disorganised neuronal spike activity, impairing the processing
of relevant information in the brain [2]. Glutamate binding
metabotropic glutamate receptors (mGluRs) are one of G-
protein-coupled receptors and exert its physiological roles
through intracellular chemical-messenger signalling cascades
[3]. Eight mGluRs (mGluR1–8) have been discovered and are
grouped into three categories: group I (mGluR1 and 5), group
II (mGluR2 and 3) and group III (mGluR4, 6, 7 and 8) accord-
ing to sequence identity, pharmacological properties and
downstream activation [4]. In general, mGluR5 combined
with glutamate activates the G-protein Gq/11, and subsequent-
ly the activated G-protein activates phospholipase C (PLC)
which hydrolyses membrane phosphoinositides to form inosi-
tol 1, 4, 5-triphosphate (IP3) and diacylglycerol (DAG). IP3
causes the release of intracellular calcium, which activates
PKC [5]. The Homer family binds to the intracellular C-
terminal tail of mGluR5 and also excites downstream effectors
(Fig. 1) [6]. It is noteworthy that mGluR5 regulates various
mechanisms implicated in neurogenesis and synaptic
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maintenance, and the abnormal regulation of mGluR5 has
been implicated in the pathophysiology of many neurological
and psychiatric disorders, including pain, epilepsy, schizo-
phrenia, drug addiction and Alzheimer’s disease [7]. Thus,
mGluR5 represents a pathophysiological hallmark for neuro-
protective agents of potential application in neurodegenerative
disorders [8].
Epilepsy is the second most common neurological disorder
after stroke and a major burden for public health systems,
afflicting worldwide approximately about 65 million people
[9]. Although current antiepileptic drugs have achieved com-
plete seizure control, they do not prevent or eliminate the
substantial behavioural, cognitive and somatic comorbidities
in many epilepsy patients [10]. New drugs with fewer side
reactions and greater efficacy are urgently needed. Epilepsy
researchers have recently embarked on a revitalise effort to
move from targeting the control of symptoms to strategies of
prevention and cure. One important direction for new thera-
peutics is identifying new molecular targets [11].
Tea is one of the most popular beverages in the world
owing to its refreshing taste and attractive aroma. Its possible
beneficial health functions have recently received much re-
search attention. Pu-erh tea, a fermented tea, produced mainly
in Yunnan province of China, is obtained by first drying crude
green tea leaves (Camellia sinensis var. assamica (L.) O.
Kuntze; Theaceae) and then subjecting them to secondary
fermentation by microorganisms, such as Aspergillus sp.,
resulting in a unique type of tea [12]. Several studies have
reported that pu-erh tea has shown a wide range of biological
effects, such as inhibiting nitric oxide production [13], pro-
moting weight loss [14], reducing blood lipids [15], exerting
antimicrobial and antitumor activities [16, 17] and scavenging
free radicals [18]. We recently also found that pu-erh tea may
reduce the incidence of epilepsy and amyotrophic lateral
sclerosis [19, 20]. These results suggest that the potential ef-
ficacy of pu-erh tea in the regulation of the nervous system.
In this study, we discovered that pu-erh tea downregulated
the transcription and translation of mGluR5 by Affymetrix
Expression microarrays experiments and Western blot. Pu-
erh tea also protected SH-SY5Y cells against apoptosis in-
duced by L-glutamate (L-Glu) and alleviated epilepsy behav-
iour by inhibiting the expression of mGluR5. The results iden-
tified mGluR5 as a target for the treatment of neurological and
psychiatric disorders and suggested that pu-erh tea might be a
potential natural source of protection against neurodegenera-
tive diseases associated with mGluR5. Accordingly, the aim
of this study was to identify the protective mechanisms of pu-
erh tea against injury to neuronal cells in vitro and in vivo.
Materials and Methods
Materials
Adult male Wistar rats (4–5 weeks old) were obtained from
the Animal Resource Center of Jilin University and housed at
22 ± 2 °C in a controlled environment with a 12-h light and
12-h dark cycle. All rats were treated humanely and in com-
pliance with the recommendations of the animal care commit-
tee of Jilin University. We used the minimum number of mice
required to draw a conclusion and tried to minimise their suf-
fering as much as possible.
3-(4, 5- Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium
bromide (MTT), and dimethyl sulfoxide (DMSO), L-Glu
were purchased from Sigma. Cell culture media, Dulbecco’s
modified Eagle’s medium (DMEM), heat-inactivated foetal
bovine serum (FBS) and trypsin were supplied by Gibco.
Antibodies were purchased from Santa Cruz (CA93446,
Fig. 1 Schematic of mGluR5
signalling pathway
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USA). A Luciferase Reporter Gene Assay Kit was purchased
from Beyotime. (RS)-2-Chloro-5-hydroxyphenylglycine
(CHPG), a selective mGluR5 agonist and 2-Methyl-
6-(phenylethynyl)-pyridine (MPEP), a selective mGluR5 an-
tagonist, were purchased from Selleckchem.
Cell Culture
The SH-SY5Y, HEK293Tand 3 T3 cell lines were cultured in
DMEM, and the Jurkat cell line was cultured in RPMI1640
medium supplemented with 10 % FBS, 100 units/mL penicil-
lin and 100 units/mL streptomycin (Invitrogen).
Cytotoxicity Assay
In the cytotoxicity assay, cells were seeded at a density of
1 × 104 cells/well in 96-well plates and incubated for 24 h.
Cells were treated with pu-erh tea at various concentrations for
24 h. MTT (5 mg/mL, 20 μL) was added to the medium 24 h
later. After incubation at 37 °C for 4 h, the supernatant was
aspirated and 100 μL of DMSO was added to each well,
followed by vibration for 10 min. The absorbance in the ex-
perimental wells was measured at 570 nm with a microplate
reader.
Affymetrix Microarrays
RNA was extracted with TRI reagent (Sigma) and DNAse I
(Invitrogen) from Jurkat in triplicate with or without pu-erh
tea treatment for 12 h. RNA quality and concentration were
assessed with an Agilent 2100 Bioanalyser and Nanodrop
ND-1000. Data from Affymetrix 430 2.0 microarray chips
(SCIBLU, Affymetrix) was analysed with Arraystar 3 soft-
ware (DNA STAR Inc.), which was quantile-normalised and
processed by the RMA (Affymetrix) algorithm.
Luciferase Assay
Promoter regions were amplified by PCR amplification and
subcloned into the KpnI/HindIII sites of the luciferase reporter
vector pGL3-Basic (Promega) upstream of the firefly lucifer-
ase gene (Fig. 2). SH-SY5Y and HEK293T cells were
transfected with mGluR5 promoter-pGL3 recombinant plas-
mid by electroporation according to the manufacturer’s in-
structions. A monolayer of 80 % confluent cells was
trypsinised, washed with appropriate media and washed again
in ice-cold PBS buffer. Cell suspension for the electroporation
was first prepared in 400 μL ice-cold PBS buffer (2.5 × 106
cells/mL) in a 0.4-cm electric rotary cup, followed by adding
10 μg plasmid. The electroporation conditions were adopted
from previous work, as follows: U = 225 V, R = ∞,
Ω = 1050 μF. After electroporation, cells were seeded in 12-
well plates at a density of 4 × 104 cells per well. After 12 h,
transfected cells were incubated with pu-erh, black and green
teas. Cells were then harvested and firefly luciferase activity
was determined using a Sirius luminometer (Berthold
Detection System). Experiments were performed in triplicates
and repeated at least three times independently.
Western Blot
Cells were prepared in ice-cold lysis buffer (100 mM NaCl,
50 mM Tris-HCl, 1 mM EDTA, 10 mMMgCl2, pH 7.2) con-
taining 1 % Triton X-100, phosphatase and protease inhibitor
cocktail (Dinggguo, China) for 10 min. Cell lysates were cen-
trifuged at 12,000g for 10 min at 4 °C, and protein concentra-
tions of supernatants were determined with BCA assay.
Lysates were added 5 × SDS containing 100 mM DTT.
Equal amounts of protein were loaded onto and separated on
12 % SDS-PAGE gels and transferred to polyvinylidene fluo-
ride (PVDF) membranes. Membranes were incubated with
primary antibodies overnight, washed three times in washing
buffer (0.1 % Tween-20 in PBS), incubated with HRP-
coupled secondary antibodies for 1 h, washed three times in
washing buffer and developed using chemiluminescent HRP
detection substrate. When proteins were extracted from hip-
pocampus tissue, hippocampus tissues were placed in lysis
buffer (as above) and homogenised for 1 min. The homoge-
nate was then centrifuged at 12,000g for 10 min at 4 °C. The
final supernatant was collected and processed as above.
Nuclear Staining with Hoechst 33342
SH-SY5Y cells were seeded in 6-well plates (1.5 × 105 cells/
well) for 24 h. Cells in a 6-well plate were incubated with pu-
erh, black or green teas for 12 h before treatment with L-Glu
for 24 h. Cells were washed with PBS and stained with
500 μL of Hoechst 33342 solution for 15 min at room tem-
perature in the dark. The nuclear morphology of the cells was
examined under a fluorescent microscope.
Flow Cytometry Analysis of Apoptosis in SH-SY5Y
SH-SY5Y cells were seeded in 6-well plates (1.5 × 105 cells/
well) for 24 h. Cells in each 6-well plate were incubated with
pu-erh, black or green teas for 12 h before treatment with L-
Glu for 24 h. Cells treated with medium alone were used
negative control. Apoptosis of cells was evaluated by mea-
surement of the exposure of phosphatidylserine on the cell
membranes using Apoptosis Detection Kits. Cell pellets were
resuspended in a staining solution containing propidium io-
dide (PI) for 5 min and Annexin V-FITC for 15 min at room
temperature in the dark. The cells were assessed by
fluorescence-activated cell sorting (FACS) using the Cell
Quest software (BD, Pharmingen).
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Calcium Imaging
SH-SY5Y cells were seeded in 6-well plates (1.5 × 105 cells/
well) for 24 h. Cells in a 6-well plate were incubated with pu-
erh, black, or green teas for 12 h before treatment with L-Glu
for 24 h. Cells treated with medium alone were used as neg-
ative control. Cells were loaded with 2 μM Fluo-3 AM at
37 °C for 1 h. Cells were suspended in PBS after being
washed three times and analysed by a flow cytometry device
equipped with the Cell Quest software at 488 nm.
Epileptic Rat Model
Status epilepticus (SE) was induced in adult Wistar rats by
using Licl-pilocarpin [21]. Rats were randomly divided into
6 groups with 6 rats in each group. Three groups were admin-
istered intragastricly with pu-erh tea at a dose of 0.5 g/Kg/day,
the other three groups were treated with saline. After 20 days,
lithium chloride was intraperitoneally injected into the four
groups rats that two of them were dministered intragastricly
with pu-erh tea, the other two were treated with saline at a
127 mg/kg dosage. After 18 h, the rats were treated with a
40 mg/kg dose of pilocarpine, administered intraperitoneally.
Two of the groups that one was treated with pu-erh tea and
Licl-pilocarpin, the other was treated with saline and Licl-
pilocarpin were treated with 4 mg/kg diazepam, before
pilocaroine administered intragastricly. Saline was adminis-
tered to the control group at the same dosage.
Behavioural Study
Rats were video monitored from day 0 to day 15 post status
epilepsy (SE) and were scored by an individual blind to the
experimental design. Behavioural seizure was recorded ac-
cording to a modification of the classification of Racine
[22]: 0, exploring; 1, immobility; 2, rigid posture; 3, head
nodding; 4, bilateral forelimb clonus and falling; 5, continued
clonus and falling; and 6, generalised tonus. Three behaviour-
al patterns of SE could be recognised: I, initial (class 1–2), M,
middle (class 3) and C, critical (class 4–6). Seizure number
and type were recorded within 1 h of the seizure in day 0.
Then, seizure number and type were recorded 30 min every
24 h from day 1 to day 15.
Measurements of IP3 and DAG
The measurement of the contents of IP3 and DAG was con-
ducted using IP3 and DAG ELISA kits (RD, USA).
Hippocampus tissues were placed in ice-cold PBS and
homogenised for 1 min. The homogenate was then centri-
fuged at 12,000g for 10 min at 4 °C. The final supernatant
was collected.
Fig. 2 Construction strategy and
structure of the recombinant
plasmid mGluR5 promoter-pGL3
Mol Neurobiol
Haematoxylin and Eosin (HE) Staining
Brains were prepared from control and post-SE rats. Animals
were anaesthetised using 20 % urethane at a dose of 0.5 mL/
kg. Once deeply anesthetised, animals underwent heart perfu-
sion with ice-cold modified PBS followed by 4 % poly-form-
aldehyde. The brain was removed and dehydrated in 20 and
30 % sucrose. The brains were then embedded in optimal
cutting temperature compound (OCT). Six-micrometre-thick
slices were made with a tissue slicer and stained in HE solu-
tions to examine morphological changes.
Immunofluorescence
To detect the expression of mGluR5 in rat brains, 6-μm
paraffin sections were subjected to antigen retrieval and
blocking of endogenous peroxidase activity, followed by
incubation with mGluR5 monoclonal antibody (diluted at
1:200) overnight at 4 °C. The sections were incubated
with FITC-conjugated anti-mouse IgG (1:250) for 2 h at
room temperature. All images were acquired with a fluo-
rescence microscope.
Statistical Analysis
All values were expressed asmean ± S.D. AOne-way analysis
of variance (ANOVA) was used to detect statistical signifi-
cance followed by post hoc multiple comparisons (Dunn’s
test) by GraphPad Prism 6.0. A value of P < 0.05 was consid-
ered to be significant [23, 24].
Results
Pu-erh Tea Down-Regulated the Transcription of mGluR5
To investigate the cytotoxicity of pu-erh tea, cell viability
assays were performed. Our finding demonstrated that pu-
erh did not inhibit the proliferation of Jurkat or SH-SY5Y at
concentrations lower than 250 μg/mL, whereas it exerted a
marked inhibitory effect on the proliferation of Jurkat and
SH-SY5Yat concentrations greater than 0.5 mg/mL. No inhi-
bition was observed in 3 T3 (Fig. 3).
The messenger RNA (mRNA) expression differences be-
tween the Jurkat cells treated and untreated with pu-erh tea
were detected with Affymetrix expression microarrays. The
results showed that pu-erh tea could downregulate mGluR5,
one of the G protein-coupled receptors implicated in the ner-
vous system (Tables 1, 2).
Pu-erh Tea Inhibited the Activity of mGluR5 Promoter
To assess the role of pu-erh tea in transcriptional regulation
and cell-specific expression of mGluR5, we constructed
mGluR5 promoter-pGL3 recombinant plasmid The PCR
products of the mGluR5 promoter were examined by 1 %
agarose gel electrophoresis (Fig. 4a). PCR product is 1167-
bp specific fragment consistent with the mGluR5 promoter.
The promoter region was then subcloned into the KpnI/
HindIII sites of pGL3-Basic. Double enzyme digestion reac-
tion yielded a clear obvious 1167-bp fragment, showing that a
recombinant plasmid, mGluR5 promoter-pGL3 had been con-
structed (Fig. 4b).
Thus, the following detection on the activity of
mGluR5 promoter to drive the expression of luciferase
was assessed in HEK293T and SH-SY5Y cel ls .
Luciferase activity driven by mGluR5 promoter was de-
creased significantly at a concentration of 62.5 μg/mL
(Fig. 4c). The transfected cells were then incubated at this
concentration for various times, with the result that at 6 h
luciferase activity was decreased significantly (Fig. 4d).
Compared to black and green teas, treatment with pu-erh
tea for 6 h had a greater suppressive effect on transcrip-
tional regulation of mGluR5 in both HEK293T and SH-
SY5Y cells (Fig. 4e, f).
Pu-erh Tea Inhibited the Expression of mGluR5
To further validate the inhibition of the expression of the
mGluR5, several concentrations of pu-erh tea, 50 μM
Fig. 3 a Jurkat cell viability after incubation with various concentration
of pu-erh tea for 24 h. b 3 T3 cell viability after incubation with various
concentration of pu-erh tea for 24 h. c SH-SY5Y cell viability after
incubation with various concentration of pu-erh tea for 24 h. Data were
analysed using the GraphPad Prism software (n = 6)
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CHPG (a selective mGluR5 agonist) and 50 μM MPEP (a
selective mGluR5 antagonist) were added to SH-SY5Y cells
and followed by incubation for 12 h. There were no effects on
the growth of SH-SY5Y at the concentration of 62.5 μg/mL
(Fig. 3c). The expression of mGluR5 was markedly reduced
compared to the control when cells were treated with 62.5 μg/
mL of pu-erh tea for 12 h compared to the control (Fig. 5a, b).
When SH-SY5Y cells were treated with 62.5μg/mL of pu-erh
tea for various times, pu-erh tea markedly inhibited the ex-
pression of mGluR5 compared to the control (Fig. 5d, e).
Compared to black and green teas, treatment with pu-erh tea
for 12 h significantly inhibited the expression of mGluR5
(Fig. 5g, h).
The Homer family of proteins is localised predomi-
nantly at the postsynaptic density (PSD) in mammalian
neurons and binds a specific proline-rich sequence on
group I mGluRs. We assayed the expression of Homer
by Western blot, and found that Homer was also signifi-
cantly inhibited by pu-erh tea at dose-dependently and
time-dependently (Fig. 5).
Effects of Pu-erh Tea on Neuronal Injury
Increase in extracellular levels of glutamate leads to activation
of mGluR5 and a strong excitatory neurotoxicity, resulting in
neuronal swelling and necrosis. To confirm that pu-erh tea
protects cells from nerve injury, SH-SY5Y cells were incubat-
ed with pu-erh tea before treatment with L-glutamate (L-Glu).
The nuclear morphology of SH-SY5Y cells was examined
after staining with Hoechst 33342. Compared to black and
green teas, 12-h treatment with 62.5 μg/mL of pu-erh tea
reduced the number of hallmarks of apoptosis induced by
160 mM L-Glu, whereas the mGluR5 agonist CHPG in-
creased and the mGluR5 antagonist MPEP decreased the
number of apoptosis (Fig. 6a).
To further investigate whether pu-erh tea protects cells
against apoptosis, the cells were analysed by flow cytometry
after staining with Annexin V-FITC and PI. The percentage of
surviving cells increased from 28.36 to 71.99 % after 12-h of
treatment with pu-erh tea, whereas the mGluR5 agonist
CHPG reduced the cell surviv to cells to 6.33 %. Treatment
with black or green tea also increased the percentage of sur-
viving cells (Fig. 6b).
Involvement of Ca2+ in Prevention of Nerve Injury
by Pu-erh Tea
The activation of mGluR5 could increase Ca2+ influx, and
excitotoxic Ca2+ elevation is an early and possibly reversible
pathological event that may lead to neuronal injury. To inves-
tigate the role of pu-erh tea in Ca2+ release in nerve injury
induced by L-Glu, SH-SY5Y cells were incubated with pu-
erh tea before treated with L-Glu, using an intracellular Ca2+
chelator (Fluo-3 AM). Pretreatment with pu-erh tea signifi-
cantly inhibited calcium influx compared to that black tea or
green teas. However, mGluR5 CHPG activated the calcium
influx (Fig. 6c).
Pu-erh Tea Inhibited PKCα Activation by L-Glu
In addition to Ca2+ release, PKCα is involved in mGluR5
signalling. After nerve injury by L-Glu, we observed that
PKCα activity was increased. Moreover, pretreatment with
the mGluR5 antagonist MPEP, inhibited PKCα activity. Pu-
erh tea significantly reduced PKCα activity compared to black
or green teas. The content of PKCα in each group did not
change. (Fig. 6d, e).
Effect of Pu-erh Tea on Behaviour
The Wistar rats that injected intraperitoneally with Licl-
pilocarpine only had obvious epilepsy behaviour, while the
groups treated with pu-erh tea onLicl-pilocarpine induced
SE significantly attenuated the maximal seizure classes and
Table 2 Pu-erh tea extract decreased the expression of the target gene
UniGene.ID Fold change Gene. title
Hs.188859 −1.705 G protein-coupled receptor 20
Hs.446091 −1.705 Wilms tumour 1 associated protein
Hs.631992 −1.717 Dystonin
Hs.122125 −1.719 Transcribed locus
Hs.697691 −1.77 Olfactory receptor
Hs.370036 −1.805 Chemokine (C-C motif) receptor 7
Hs.135232 −1.817 Transcribed locus
Hs.147361 −1.936 Metabotropic glutamate receptor 5
Hs.224012 −1.995 Jagged 1 (Alagille syndrome)
Hs.5462 −2.017 Solute carrier family 4
Hs.1466 −2.039 Glycerol kinase
Hs.660607 −2.073 Oestrogen receptor 2 (ER beta)
Hs.76884 −2.317 Inhibitor of DNA binding 3
Hs.504609 −4.464 Inhibitor of DNA binding 1
Table 1 Pu-erh tea extract increased the expression of target genes
UniGene.ID Fold change Gene. title
Hs.520028 14.54148 Heat shock 70 kDa protein 1 A
Hs.654614 10.09114 Heat shock 70 kDa protein 6
Hs.591670 6.948213 Inhibitor of DNA binding 2
Hs.658815 6.465138 Transcribed locus
Hs.525704 5.117358 Jun oncogene
Hs.155569 4.549088 ChaC
Hs.370699 3.700921 Hypothetical protein LOC284801
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the predominant behavioural seizure patterns in SEmice com-
pared with the control (Table 3, n = 6).
Pu-erh Tea Prevents Epilepsy by Inhibiting mGluR5
IP3 and DAG, as second messengers, play important roles on
in intracellular messenger transduction. These two substances
stimulate neurons and can cause neuronal damage if present in
excess. We accordingly assayed the contents of IP3 and DAG
in the hippocampus by ELISA to confirm the effect of pu-erh
tea on prevention of epilepsy. The results showed that IP3 and
DAG were increased in epilepsy and decreased under
intragastric administration of pu-erh tea (Fig. 7a, b).
Histological images using HE staining showed that after epi-
lepsy rat hippocampus showed injury, whereas before
intragastric administration of pu-erh tea or diazepam, rat hip-
pocampus showed no changes compared to the control
(Fig. 7c).
To determine whether mGluR5 is implicated in epilepsy,
we used immunofluorescence and Western blot assays. In the
immunofluorescence assays, the expression of mGluR5 was
significantly upregulated in epileptic rats only administrated
intraperitoneally with Licl-pilocarpin compared to others,
whereas the rats before intragastric administration of pu-erh
tea or diazepam showed reduced expression of mGluR5 com-
pared to that in epilepsy (Fig. 7d, e). In Western blot, we also
found the similar result (Fig. 7f, g).
Discussion
In the present study, we observed that pu-erh tea decreased the
mGluR5 promoter activity and downregulated the expression
of the mGluR5 at dose-dependently and time-dependently.We
also discovered that pu-erh tea protected SH-SY5Y cells
against apoptosis induced by L-glu via blocking Ca2+ influx
and inhibiting the PKCα activation. Pu-er tea had the role of
alleviating epilepsy and reducing the expression ofmGluR5 in
epilepsy rats.
Human epidemiological and animal research experiments
suggest that the pharmacological benefits of tea drinking may
help protect the brain. And tea drinking has been shown to
exert neuroprotective activities in a wide array of cellular and
animal models of neurological disorders [25]. The Affymetrix
Fig. 4 a Agarose gel electrophoresis of mGluR5 promoter. M: 2000
DNA marker; 1:mGluR5 promoter PCR product. b Agarose gel
electrophoresis of mGluR5 promoter-pGL3 double restriction enzyme
digestion. M: 2000 bp; 1: mGluR5 promoter-pGL3 double restriction
enzyme digestion; 2: mGluR5 promoter-pGL3 KpnI restriction enzyme
digestion; 3: mGluR5 promoter-pGL3 HindIII restriction enzyme diges-
tion. c Luciferase activity after treatment with various concentrations of
pu-erh tea for 12 h. d Luciferase activity after treatment with 62.5 μg/mL
pu-erh tea for various times. e Luciferase activity after treatment with
62.5 μg/mL pu-erh, black, green teas for various times. f Luciferase
activity after treatment with 62.5 μg/mL pu-erh, black, green teas for
6 h. Data were analysed using the GraphPad Prism software
(***p < 0.001 vs. vehicle control, n = 6)
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expression microarrays showed that 0.25 mg/mL pu-erh tea
decreased the mGluR5. Our results that pu-erh tea showed no
toxicity to tumour cells and normal cells at low concentrations
(≤ 0.25 mg/mL) was in accordance with the report that pu-erh
tea showed no signs of toxicity and no deaths in SD rats at
dosages ≤10 g/kg [26]. These results indicated that the reduc-
tion of mGluR5 mRNA and protein by pu-erh tea was not the
result of cell death at low concentration (≤ 0.25 mg/mL).
Excessive mGluR5 activation has already been alluded
to as a potential contributing factor in synaptic disorders,
and a number of studies are currently testing the therapeu-
tic potential of drugs that modify mGluR5 [27]. The mod-
ification of particular mGluR5 has been implicated in syn-
aptic diseases and psychiatric disorders [28]. Despite
progress in drug treatment of schizophrenia, cognitive
and other negative symptoms remain a major issue of
the disease, often representing residual symptoms of re-
sistant schizophrenia and being worsened by the side ef-
fects of antipsychotics effects [29].
The mGluR5 promoter we cloned could regulate the ex-
pression of luciferase (Fig. 4). It was consistent with the result
that the alternative 5-splicing and usage of multiple promoters
may contribute regulatory mechanisms for tissue- and
context-specific expression of the mGluR5 gene [30]. The
results of luciferase assays (Fig. 4) and Western blot (Fig. 5)
suggested that pu-erh tea contains active compounds that
could inhibit the transcription and the translation of mGluR5
compared to black tea and green tea. It may be during the
fermentation, the types, activity and content of the compo-
nents in pu-erh tea are different from those of black and green
teas [31]. Owing to the complexity of the composition of pu-
erh tea, the active ingredients that protect neural cells via re-
ducing the expression of mGluR5 await further study. The
mGluR5 agonist CHPG increased the expression of mGluR5
and an mGluR5 antagonist MPEP reduced the expression of
mGluR5 (Fig. 5). These results suggested that pu-erh tea was a
candidate as mGluR5 antagonist.
Importantly, the activity of mGluR5 is tightly regulated by
its association with scaffolding protein, Homer [32]. In
Western blot, we found that pu-erh tea could downregulate
the expression of Homer significantly compared to black or
green teas (Fig. 5). Homer proteins share a commom Ena/
Fig. 5 The expression of mGluR5 and Homer were detected byWestern
blot and analysed by ImageJ. a–c Cells were treated with various
concentrations of pu-erh tea for 12 h. d–f Cells were treated with
62.5 μg/mL pu-erh tea for 3, 6, 9, 12 h. g–i Cells were treated with
62.5 μg/mL pu-erh, black, or green teas for 12 h. Data were analysed
using GraphPad Prism software (***p < 0.001 vs. vehicle control,
**p < 0.01 vs. vehicle control, n = 3)
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Vasp homology protein (EVH1) domain at the N-terminus
that binds to the intracellular C-terminal tail of mGluR5 and
localises mGluR5 to the postsynaptic density (PSD) [6, 33,
34]. In addition, it has been shown that disruption of mGluR5-
Homer interactions selectively blocks mGluR5 activation
[35]. These results indicated that the inhibition of mGluR5
by pu-erh tea disrupted mGluR5–Homer scaffolds, resulting
in decreasing Homer.
Fig. 6 a Image of Hoechst 33342-stained cells. b Flow cytometry anal-
ysis of apoptosis. c Flow cytometry analysis of Ca2+ influx. d Western
blot analysis of PKCα activity. e Quantification of protein level from
three independent experiments using ImageJ. Cells were pretreated with
62.5 μg/mL pu-erh, black, or green teas for 12 h before treatment with
160 mM L-Glu. Data were analysed using GraphPad Prism software
(***p < 0.001, n = 3)
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A recent study suggests that enhanced mGluR5-Homer
binding leads to a reduction in mGluR5-induced cytosolic
Ca2+ increase [36]. However, in our study, both L-Glu and
mGluR5 agonist CHPG induced nerve cell necrosis and in-
creased intracellular Ca2+ response. These findings are in
agreement with the report that Homer proteins bind IP3 recep-
tor [37]. IP3 induces calcium release from intracellular stores,
potentially leading to cell death [38]. Pretreatment with pu-erh
tea or an mGluR5 antagonist MPEP could protect cells from
necrosis and decrease intracellular Ca2+ response. These re-
sults suggested that pu-erh tea had the role of mGluR5 antag-
onist that prevented Homer binding IP3 receptor, which con-
tributed to blocking the glutamate stimulation and inhibiting
the release of intracellular Ca2+ in response to neuronal injury.
The mGluR5-induced Ca2+ response could also be nega-
tively regulated by Homer 1a under some condition [39].
Given that group I mGluRs are positively coupled to PLC,
leading to PKC activation and phosphorylation of serine 839
mediated by PKC activation is involved in the regulation of
mGlu5 receptor-mediated Ca2+ influx [40, 41]. Therefore,
Table 3 Effect of pu-erh tea on SE class
Pu-erh tea − − − + + +
LiCl-pilocarpine − + + − + +
Diazepam − − + − − +
Behaviour (times) I/Class 1–2 0 32 5 0 8 4
M/Class 3 0 51 1 0 5 0
C/Class 4–6 0 64 0 0 0 0
Fig. 6 continued.
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we wondered whether the ability of pu-erh tea to attenuate
the release of intracellular was dependent mGluR5-PKC. We
tested the activation of PKCα and found that both L-Glu
and the mGluR5 agonist CHPG stimulated PKC activation,
whereas pu-erh tea or an mGluR5 antagonist MPEP
inhibited PKCα activation. Thus, we theorise that pu-erh
tea protected neuronal injury by inhibiting PKC activation
which resulted from inhibiting the release of intracellular
Ca2+. However, PKC isoenzymes have been classified into
two subfamilies: the conventional subtypes (cPKC: α, βI,
βII, γ) are Ca2+ and DAG-dependent and novel subtypes
(nPKC: δ, γ, η, θ,) are DAG-dependent, but Ca2+-indepen-
dent [42]. Group I mGluRs coupled to Gαq/11 proteins
stimulate the activation of PLC, resulting in DAG formation.
Pu-erh tea decreased the contents of IP3 and DAG in the
hippocampus (Fig. 7a, b). Accordingly, whether pu-erh tea
influences the novel subtypes of PKC awaits further
investigation.
Fig.7 a Content of IP3 in the hippocampus. b Content of DAG in the
hippocampus. c HE staining of hippocampus. d Immunofluorescence of
hippocampus with Hochest 33,342 (blue) and anti-mGluR5 (green). e
Quantification of relative fluorescence intensity of mGluR5/Hochest
33342 by ImageJ. f Western blot analysis the expression of mGluR5 in
the hippocampus. g Quantification of protein levels from three indepen-
dent experiments by ImageJ. Data were analysed using GraphPad Prism
software (***p < 0.001, **p < 0.01, *p < 0.05, n = 3)
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mGluR5 is well known to play important roles in neuronal
function and synaptic plasticity, and defects in mGluR5 signals
are thought to cause a variety of neurological disorders.
Activation of mGluR5 increases epileptiform activity and an
mGluR5 antagonist MPEP inhibits convulsive and non-
convulsive primary generalised seizures [43]. In this study,
we constructed an epilepsy model by using Licl-pilocarpin
[21]. Pilocarpine activates the G-protein which mediates the
receptor stimulation to PLC. PLC hydrolyses PI into IP3 and
DAG. IP3 and DAG cause neuronal stimulation and when in
excess, may contribute to neuronal injury [44]. In general,
mGluR5 combined with glutamate activates the G-protein
Gq/11, and subsequently, the activated G-protein activates
PLC which hydrolyses membrane phosphoinositides to form
IP3 and DAG [5]. We found that pu-erh tea could decrease the
severity of seizure behaviours and the content of IP3 and DAG.
Immunofluorescence andWestern blot both showed that pu-erh
tea reduced the expression of mGluR5 that was increased in
epilepsy rats. These results coincide with that the expression of
mGluR5 is higher in the hippocampus of epileptic patients,
than in those of a control group [45]. The results indicated that
pu-erh tea could decrease the content of IP3 and DAG through
reducing the expression of mGluR5. Taken together, these re-
sults indicate that pu-erh tea played an important role in
protecting neural cells from injury induced by glutamate and
antiepileptic via inhibiting the activity of mGluR5 promoter
and the expression of mGluR5 (Fig. 8).
Conclusion
Dysregulation of mGluR5 is implicated in multiple brain dis-
orders. Accordingly, many selective mGluR5 antagonists
have been developed for clinical therapy. However, these
drugs have produced unacceptable side effects in clinical tri-
als. The findings of this study suggested that pu-erh tea can
inhibit mGluR5 activation stimulated by glutamate via
inhibiting the activity of mGluR5 promoter and the expression
of mGluR5, which blocks Ca2+ influx and suppresses the ac-
tivity of PKC α to protect nerve cell from necrosis. Pu-erh tea
also relieves rat epilepsy and reduce the contents of IP3 and
DAG in epilepsy rats. These results suggest that pu-erh tea is a
potential neuroprotective agent acting via regulation of
mGluR5. However, the specific compounds in pu-erh tea that
function in neural protection await further study.
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